Clinical Trial Detail

NCT ID NCT01562899
Title A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Array BioPharma
Indications

colorectal cancer

Advanced Solid Tumor

pancreatic adenocarcinoma

melanoma

Therapies

Binimetinib + Ganitumab

Age Groups: senior adult

Additional content available in CKB BOOST